Chinese Covid-19 Vaccine Research and Development Start Date Raises Concern
Friday 16 July 2021 – EPOCH TIMES
Even before the MMR virus began to spread in China, by the fall of 2019, its vaccine was already spreading around the world. So, as a result of the analysis of the chronology of the R&D process (research and development) of vaccines produced in China, a series of incomprehensible anomalies emerged that made the world community question the origin of the Covid-19 virus. In addition, the Chinese Communist Party (CCP) vaccine production plan reveals the regime’s desire to take advantage of the pandemic.
Start Date of Chinese Research and Distribution of Anti-Covid Vaccine
According to official figures, the first case of the PDA virus, now commonly referred to as the coronavirus, was reported on December 1, 2019; and on January 21, 2020, only 440 people were reported as having had exposure to the virus. On January 15, 2020, 8 health reports from the Wuhan City Health Commission noted that “there is no clear evidence of human-to-human transmission” and it has not “been found to date.” If this was accurate information, then it would appear that the Chinese regime did not expect the virus to spread throughout the world, and was not ready for such an event.
However, on March 25 this year, in the state media article Beijing Daily, the fact of the leak leads the story of events in the opposite direction. This text indicated that the CCP has formulated five points of the R&D strategy for vaccine distribution in early 2020; one of the five vaccine technologies came from Major General Shen Wei, the CCP’s chief military biochemical weapons expert, and his team. This news is both suspicious and requires reflection.
Immediately following the identification of the source of the virus by Hubei province scientists on January 9, 2020, local authorities have formed a joint team from the Wuhan Institute of Virology (WIV) and the Wuhan Institute of Biological Products to develop a vaccine against the CCP virus, according to Chinese state media reports.
Taking into account all the R&D groups involved in these vaccines, the timeline for two enterprises was announced: the R&D for the officially approved Sinopharm vaccine on January 19, 2020, and the CanSino Biologics Covid-19 vaccine project from Tianjin was approved and launched on January 20, 2020.
Three questions arise.
First, if the original viral sequence really has a natural origin (for example, all the evil came from several bats), as the CCP claims, and which are incapable of transmission from person to person, why are military biological warfare specialists involved in the study and development of a vaccine in large scale?
Second, the CCP began researching and developing many vaccines even before Wuhan was confirmed on January 23, 2020, indicating that it was clear to the CCP that the virus would manifest globally. In this case, why was it necessary to spread lies, claiming that the virus is not too contagious? This absurdity only contributes to the faster spread of the virus around the world.
Third, by the beginning of 2020, all types of vaccines from that period were ready for use (all were not commercially available). Why was Wuhan not involved at this moment? Wasn’t the number of infected and deaths minimized in this way? Reasonable people may come to the conclusion that the CCP’s actions in the first phase of the pandemic do not have clear answers, and the regime did not seek to contain the influence of the virus in order to prevent its spread throughout the world.
Were Chinese vaccines ready even before the pandemic?
Prashan Yadav, an expert in the supply of medicines at the Center for World Development from the group of international studies, emphasized that “the creation of a vaccine is a whole production in which an almost infinite number of elements must be perfectly combined.”
“The basic elements, the microorganisms needed to make a vaccine, the living conditions for these microorganisms, and so on, are very diverse,” Mr. Yadav told USA Today.
As a consequence, it takes many years to develop a prototype vaccine and further develop new vaccines. However, China seems to be well aware of this vaccine.
It is widely known that a prototype vaccine used in clinical trials must go through a long development process. The Pfizer vaccine began development for use on March 20, 2020, and it took at least 4 months to create a product ready for marketing. And the media of the Chinese state reported that Sinopharm began to create R&D on January 19, 2020, and clinical trials took place on April 12 of the same year.
Sinopharm got the job done much faster than Pfizer’s vaccine was created, indicating that the PDA was ready for a pandemic even before it began, as evidenced by the time the vaccine was created.
How China quickly and massively produced the Covid vaccine
There are at least 7 vaccine manufacturers in the world today: Pfizer, Moderna, AstraZeneca, J & J / Janssen, Sinopharm, Sinovac and Covishield. When American vaccines were released in late 2020, Pfizer’s vaccine production capacity was rather weak, only today reaching 100 million doses per month. However, Chinese vaccines had the same volume a year before Pfizer.
In the US, the Pfizer vaccine was the subject of research and development at the end of March last year; they then proceeded to its derivatives and three stages of clinical trials before final use and release to the market. This process took them about 9 months. The Pfizer team themselves did not believe that they managed to do everything with such speed. It took several months of work to produce 100 million doses in a month. It took Pfizer about a year from launching the program to releasing the vaccine on a large scale.
China joined the World Health Organization’s COVAX plan in early October, providing vaccine and paying for the vaccine to 92 low-budget countries. When China joined the plan, Zheng Zhongwei, head of the vaccine R&D team of the CCP State Council’s Prevention and Control Mechanism, said that China’s annual vaccine production capacity could reach 610 million doses from the end of 2020.
In other words, from late summer to early fall 2020, Chinese vaccine production will approach the monthly production of hundreds of millions of doses. Therefore, in the first months of this year, it was Chinese vaccines that dominated global production. European and American vaccines did not begin to appear until late 2020, and it took another three months before they were mass-produced. Compared to Chinese, European and American vaccines appeared later, and their quantity clearly did not meet the needs of both countries themselves and others. There remained a window of about six months until the Chinese vaccine became universal in the world.
Even if the competence of China in the very topic of vaccine research and the possibility of its production has reached the level of the United States, the microorganism culture process necessary for clinical research and vaccine production can neither be copied nor accelerated. As a consequence, the shortest time it took for China to start production on a large scale should be the same as that of the United States, that is, about a year. If we assume that the Chinese vaccine reached a mass scale of 100 million doses per month at the beginning of last fall, the CCP had to start preparatory work on this culture, the identification and testing of microorganisms in the fall of 2019.
Chinese authorities claim that the first infected with the virus was observed in Wuhan on December 1, 2019, but this lie was exposed by its own chronology, indicating accelerated mass production. Based on these data, in the fall of 2019, the CCP had at its disposal not only the new coronavirus, but had already mastered a number of different types of vaccines that could be used, and even began preparations for its mass production. It had to proceed from the principle that the epidemic would soon manifest itself in other countries, causing devastation to the whole world.
The CCP prioritizes vaccine exports and inhibits domestic vaccinations
When Chinese vaccines were already produced on a large scale, they were not used in China. On the one hand, China stockpiled hundreds of millions of doses, on the other hand, vaccines were sent to other countries for clinical trials, thus paving the way for the export of vaccines on a large scale.
Since July 2020, the Sinopharm vaccine has begun phase III clinical trials in the United Arab Emirates. These clinical trials included 40,832 people in the UAE, Bahrain, Egypt and Jordan. The CoronaVac Sinovac vaccine was also pioneered in Phase III c samples. Brazil, Turkey, Indonesia and Chile on July 21, 2020. At this time, the United States was still in the initial research phase for vaccine development.
Why didn’t the CCP proactively announce in June 2020 that it was ready to mass-produce a vaccine made in China when it was about to organize mass trials in other countries?
The CCP, well known for its deceptions, decided not to bluff this time, as two factors had to be taken into account. First, if it was announced that the vaccine was already ready for mass production last June, its secrecy would inevitably be revealed, and the whole world could suspect the CCP of having made the vaccine even before the epidemic took over the world. … Secondly, the CCP had to wait until the epidemic spreads to other countries in order to be able to conduct clinical trials in some countries, in order to acquire the necessary importance for the sale of the vaccine around the world.
This first factor shows that the CCP, already having the ability to mass produce the vaccine in June 2020, should have been hiding this information. As a consequence, the Chinese authorities did not begin mass vaccination at the state level at a time when it was urgently needed to contain the virus.
Moreover, the CCP deliberately postponed the time of nationwide vaccination in order to promote it to other countries. According to a recent report from the United Daily News de Taïwan, Beijing has begun selling or donating about 700 million doses of the vaccine to over 90 countries as of June 7, 2021.
The Chinese state press agency Xinhua News Agency indicated on January 13, 2021 that only 10 million doses of the vaccine had been administered in China. By this date, the annual production of the vaccine in China has already reached 600 million doses.
According to information released by the State Health Commission, mass vaccinations in China began only in March of this year, and the total number of vaccination doses was only 80 million as of March 23, 2021, that is, this is only an eighth of the annual production in China.
Then, universal vaccinations reached 250 million at the end of April and one billion by June 21.
Why was mass vaccination in China held back until March? Because the Covid vaccine made in Europe and the US went into mass production this month and the vaccines preferred by the West are much stronger than the Chinese vaccine. Realizing how difficult it is to compete with the West in the effectiveness of the vaccine, the CCP had to seize on the possibility of quick action in a short time – urgently, while the West had not yet produced a large amount of vaccine, to receive income from the export of the vaccine. The fact that the CCP has prioritized vaccine exports, to the detriment of vaccination in the country, reveals its malicious intent to allow the virus to spread freely around the world, and as a result, to benefit from the pandemic.
China defraudes international buyers with little convincing clinical trials
With the goal of rapidly marketing large quantities of the Chinese vaccine, while the American vaccine was not yet available, the CCP conducted clinical trials in other countries in great haste. Both the Chinese Sinopharm and Sinovac vaccines were finally clinically studied in Phase III in the fall of 2020, but the report of Sinopharm’s Phase III clinical trials was delayed until March 2021. It was then published in the Journal of the American Medical Association (JAMA) only on May 26, 2021. By May 26, the CCP had already made a lot of money through the pandemic.
As soon as the clinical phase III report of the Sinopharm vaccine was published, it raised concerns.
Bloomberg writes on May 27 this year that Chinese vaccine manufacturers have come under heavy criticism for not reporting enough data on the safety and effectiveness of the vaccine.
“The tests reflected the condition of only about 85% of the male participants. Less than 2% were 60 or more years old and most were doing well. This is too inconclusive evidence of the effectiveness and safety of the vaccine for women, the elderly and those who suffer from common diseases, ”- stated in the message.
Don Juhon, an expert on virology from Europe, believes that these clinical studies do not have sufficient data to prove the vaccine’s ability to protect its recipient from serious symptoms.
The Bloomberg report highlights that the WHO (OMS) has given the green light to the Chinese Sinopharm vaccine for the world, despite the rush to research. To this day, the WHO has not given official approval for the use of the Chinese vaccine Sinovac, since the report on its clinical studies has not been published. However, the CCP has already sold 380 million doses of Sinovac vaccine overseas.
Voice of America released three new discoveries on the origins of the virus on June 27 following a worldwide investigation.
- the first case of the virus was identified in China two months before the date indicated by China itself, and the virus spread around the world before it was confirmed in Wuhan;
- the virus that appeared at the very beginning has already shown an amazing adaptability to the human body, which does not exclude the possibility of a leak from the laboratory;
- Chinese experts destroyed samples of the virus at an early stage, which is seen as an attempt to destroy evidence and cover up the origin of the virus.
I hope that we will be able to reveal the truth about the CCP’s cover-up of the origin of Covid-19.
Shen Syaonon (Cheng Xiaonong) specializes in politics and economics, lives in New Jersey. Shen was a political advisor and assistant to the former leader of the Chinese Communist Party Zhao Ziyang. He is the editor-in-chief of Modern China Studies.
The views expressed in this article are those of the author and do not necessarily reflect the views of the editors of the Epoch Times.
A source: The epoch tmes